Proteolipid protein (PLP) is the major protein component of CNS myelin and appears to be a major target of immune responses both in murine models of experimental autoimmune encephalomyelitis (EAE) and perhaps in human multiple sclerosis (MS). A chronic-relapsing form of EAE (R- EAE) is induced in inbred SJL/J mice following either active immunization with intact PLP of the major encephalitogenic determinant of the PLP molecule which encompasses amino acids 139-151 (PLP139-151), or the adoptive transfer of T cell lines/clones specific for the PLP139-151 epitope. PLP-induced R-EAE follows a relapsing-remitting course of paralysis and is characterized histologically by perivascular mononuclear cell-rich infiltrates of the white matter of the central nervous system (CNS) and areas of acute and chronic demyelination. The well-understood genetics of the murine host and the similarities in both clinical course and histopathology of murine R-EAE and MS make it an ideal animal model for the study of immunoregulatory aspects of oral tolerance. We will address the cellular and molecular mechanisms of oral tolerance induction by the intragastric (i.g.) administration of PLP and PLP139-151. Our central hypothesis is that oral antigen administration induces anti-inflammatory cytokine expression patterns that result in systemic immune tolerance. This anti-inflammatory cytokine expression regulates costimulatory molecule expression, inflammatory cytokine expression, and lymphoid cell trafficking events. This hypothesis will be tested by the following specific aims: 1) examination of oral antigen regulation of costimulatory molecule expression; 2) combinatorial use of oral antigen administration and costimulatory molecules antagonists for the treatment of ongoing EAE; 3) examination of cytokine regulation of oral tolerance induction during ongoing and relapsing EAE; and 4) examination of antigen-specific T cell trafficking after antigen feeding, including cytokine and adhesion molecule regulation of lymphocyte trafficking patterns. These studies should lead to a better understanding of the immunoregulatory mechanisms of oral tolerance which could potentially be used to control pathologic T cell-mediated immune responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI035934-08
Application #
6362320
Study Section
Special Emphasis Panel (ZRG1-BDCN-4 (01))
Program Officer
Ridge, John P
Project Start
1994-05-01
Project End
2004-02-29
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
8
Fiscal Year
2001
Total Cost
$250,551
Indirect Cost
Name
Northwestern University at Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Depaolo, R William; Lathan, Rashida; Rollins, Barrett J et al. (2005) The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection. Infect Immun 73:6514-22
DePaolo, R William; Lathan, Rashida; Karpus, William J (2004) CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT. J Immunol 173:314-20
Dogan, Rukiye-Nazan E; Karpus, William J (2004) Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation. Front Biosci 9:1500-5
DePaolo, R William; Rollins, Barrett J; Kuziel, William et al. (2003) CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance. J Immunol 171:3560-7
Karpus, W J (2001) Chemokines and central nervous system disorders. J Neurovirol 7:493-500
Kennedy, K J; Karpus, W J (1999) Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis. J Clin Immunol 19:273-9
Hoffman, L M; Fife, B T; Begolka, W S et al. (1999) Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J Neurovirol 5:635-42
Hoffman, L M; Karpus, W J (1998) Chemokine regulation of CNS T-cell infiltration in experimental autoimmune encephalomyelitis. Res Immunol 149:790-4;discussion 846-7, 855-60
Karpus, W J; Kennedy, K J; Kunkel, S L et al. (1998) Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med 187:733-41
Karpus, W J; Ransohoff, R M (1998) Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161:2667-71

Showing the most recent 10 out of 14 publications